Canada OKs use of Hologic's HPV test on molecular Dx platform

11/18/2013 | GenomeWeb Daily News (free registration)

Hologic has won approval in Canada for use of its mRNA-based human papillomavirus test on the company's Panther molecular diagnostic platform. The Aptima HPV test is a nucleic acid amplified assay used to diagnose 14 high-risk strains of HPV linked to precancerous lesions and cervical cancer.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC